Proxy Votes Now

Home › Funds › T. Rowe Price › T. Rowe Price Moderate Allocation Portfolio

T. Rowe Price Moderate Allocation Portfolio (QAAGRX) proxy voting record 2025-2026

Fund family: T. Rowe Price · Filed by T. Rowe Price Equity Series, Inc. (CIK 918294) · SEC series S000002079

Ticker: QAAGRX (C000005442)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 6,314 with, 206 against, 3 abstentions (not counted as with management); 18 items carried no recommendation; 6 split votes are in neither count. Shareholder proposals: 25 FOR, 183 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with T. Rowe Price as a whole

The same two figures as T. Rowe Price’s manager page (244,024 ballot items across 112 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsT. Rowe PriceItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.9%5,75193.7%208,710
Backed environmental and social shareholder proposals at US companies2.1%942.6%3,333

Where this fund voted differently from most T. Rowe Price funds

Each ballot item this fund voted is set against the votes of the other T. Rowe Price funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most T. Rowe Price funds on 86 items (1.3% of the 6,388 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
PROCEPT BioRobotics Corporation2026-06-09Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers.AgainstFOR — 11 of 11 T. Rowe Price fundsAgainstApproved, 73.1% support
Rambus Inc.2026-04-23Election of Directors: Meera RaoForAGAINST — 14 of 16 T. Rowe Price fundsForPassed (calculated), 93.9% support
Rambus Inc.2026-04-23Election of Directors: Necip SayinerForAGAINST — 14 of 16 T. Rowe Price fundsForPassed (calculated), 93.5% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Ian ClarkWithholdFOR — 16 of 19 T. Rowe Price fundsAgainstElected, 65.0% support
Guardant Health, Inc.2026-06-17Election of Class II Directors: Manuel Hidalgo MedinaWithholdFOR — 16 of 19 T. Rowe Price fundsAgainstElected, 75.5% support
PPG Industries, Inc.2026-04-16Shareholder Shareholder proposal to adopt a policy requiring an independent board chair, if properly presentedForAGAINST — 6 of 6 T. Rowe Price fundsAgainstNot approved, 32.0% support
Viper Energy, Inc.2026-05-19The approval, on an advisory basis, of the compensation of the Company's named executive officers.ForAGAINST — 15 of 18 T. Rowe Price fundsForApproved, 86.8% support
Viper Energy, Inc.2026-05-19The approval of an amendment to the Company's certificate of incorporation to provide that stockholders holding at least 20% of the voting power, determined on a net long basis, continuously for at least one year, may call special meetings of stockholders, and other immaterial changesAgainstFOR — 12 of 14 T. Rowe Price fundsAgainst—
Weatherford International plc2026-06-11Scheme Related Business If the Scheme of Arrangement proposal is approved at the Court Meeting: To approve the Scheme of Arrangement by, and on behalf of, Weatherford International plc ("Weatherford-Ireland') and to authorize the directors of Weatherford-Ireland to take all such actions as they consAgainstFOR — 10 of 12 T. Rowe Price fundsAgainstPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To agree to a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014, as amended, substantially in the form attached as Annex C to the Proxy Statement, that, once it becomes effective, will result in you owning common stock of Weatherford International Corp Instead of ordinary shaAgainstFOR — 10 of 12 T. Rowe Price fundsAgainst—
Weatherford International plc2026-06-11To approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement.AgainstFOR — 10 of 12 T. Rowe Price fundsAgainstPassed (calculated), 63.9% support
Weatherford International plc2026-06-11To approve an amendment to the Weatherford-Ireland Articles so that any Weatherford-Ireland ordinary shares that are issued on or after the Voting Record Time to persons other than Weatherford-US or its nominee(s) will either be subject to the terms of the Scheme of Arrangement or will be immediatelAgainstFOR — 10 of 12 T. Rowe Price fundsAgainstPassed (calculated), 61.0% support
Weatherford International plc2026-06-11To approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford International Corp ("Weatherford-US") in connection with the Scheme of Arrangement.AgainstFOR — 10 of 12 T. Rowe Price fundsAgainstPassed (calculated), 64.7% support
Weatherford International plc2026-06-11To authorize the directors of Weatherford-Ireland to allot and issue further new Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement to be paid up by the application of certain reserves as described in the Scheme of Arrangement.AgainstFOR — 10 of 12 T. Rowe Price fundsAgainstPassed (calculated), 66.3% support
Marex Group plc2026-05-21Amend Articles of AssociationAgainstFOR — 9 of 11 T. Rowe Price fundsAgainst—
Marex Group plc2026-05-21Approve Capital Reduction by Cancellation and Extinguishment of the Deferred SharesAgainstFOR — 9 of 11 T. Rowe Price fundsAgainst—
Marex Group plc2026-05-21Approve Capital Reduction by Cancellation and Extinguishment of the Scheme SharesAgainstFOR — 9 of 11 T. Rowe Price fundsAgainst—
Marex Group plc2026-05-21Approve Scheme of ArrangementAgainstFOR — 9 of 11 T. Rowe Price fundsAgainst—
Marex Group Plc2026-05-21Approve Scheme of ArrangementAgainstFOR — 9 of 11 T. Rowe Price fundsAgainst—
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Caren DeardorfWithholdFOR — 10 of 13 T. Rowe Price fundsAgainstPassed (calculated), 75.7% support
Crinetics Pharmaceuticals, Inc.2026-06-18To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders: Stephanie S. Okey, M.S.WithholdFOR — 10 of 13 T. Rowe Price fundsAgainstPassed (calculated), 74.5% support
Rocket Companies, Inc.2026-06-10Election of Class III Directors: Varun KrishnaWithholdFOR — 11 of 15 T. Rowe Price fundsAgainstPassed (calculated), 87.9% support
Planet Fitness, Inc.2026-05-05Election of the four director nominees named in the proxy statement as set forth below: Enshalla AndersonForWITHHOLD — 12 of 17 T. Rowe Price fundsForElected, 92.2% support
Planet Fitness, Inc.2026-05-05Election of the four director nominees named in the proxy statement as set forth below: Stephen Spinelli, Jr.ForWITHHOLD — 12 of 17 T. Rowe Price fundsForElected, 73.5% support
Ionis Pharmaceuticals, Inc.2026-06-04Election of Directors: Joan E. HermanForAGAINST — 13 of 19 T. Rowe Price fundsForPassed (calculated), 96.4% support
Show all 86
Items 26 to 86.
CompanyMeetingItemThis fundMost T. Rowe Price fundsMgmtResult
Dianthus Therapeutics, Inc.2026-05-21To elect Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Anne McGeorgeWithholdFOR — 9 of 13 T. Rowe Price fundsAgainstPassed (calculated), 80.6% support
Impinj, Inc.2026-05-28Election of Directors: Steve SanghiAgainstFOR — 7 of 10 T. Rowe Price fundsAgainstElected, 68.1% support
Kodiak Sciences Inc.2026-06-02Elect three Class II directors nominated by our board and named in this proxy statement: Charles A. BancroftWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstElected, 78.7% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.WithholdFOR — 8 of 12 T. Rowe Price fundsAgainstElected, 73.5% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: Jennifer CookWithholdFOR — 8 of 12 T. Rowe Price fundsAgainstElected, 60.9% support
Installed Building Products, Inc.2026-05-19Election of Directors to serve for three-year terms: Robert H. SchottensteinForAGAINST — 6 of 9 T. Rowe Price fundsForElected, 93.9% support
Xenon Pharmaceuticals Inc.2026-06-02To approve the Corporation's 2026 Equity Incentive Plan;ForAGAINST — 6 of 9 T. Rowe Price fundsForApproved, 68.0% support
Marqeta, Inc.2026-06-10To approve, on a non-binding advisory basis, the compensation of our named executive officers.AgainstFOR — 7 of 11 T. Rowe Price fundsAgainstPassed (calculated), 78.5% support
MapLight Therapeutics, Inc.2026-06-23To elect the three Class I Director nominees named in the Proxy Statement to serve until the 2029 annual meeting of our stockholders and until their successors have been duly elected and qualified, or until their earlier death, resignation or removal: Martin BablerWithholdFOR — 7 of 11 T. Rowe Price fundsAgainst—
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorAgainstFOR — 8 of 14 T. Rowe Price fundsAgainstElected, 91.7% support
Dutch Bros Inc.2026-05-13Election of Directors: Travis BoersmaAgainstFOR — 8 of 14 T. Rowe Price fundsAgainstElected, 95.6% support
Almonty Industries Inc.2026-06-09Elect Director Andrew FrazerAgainstFOR — 7 of 12 T. Rowe Price fundsAgainst—
Almonty Industries Inc.2026-06-09Elect Director Daniel D'AmatoAgainstFOR — 7 of 12 T. Rowe Price fundsAgainst—
Almonty Industries Inc.2026-06-09Elect Director David HanickAgainstFOR — 7 of 12 T. Rowe Price fundsAgainst—
Almonty Industries Inc.2026-06-09Elect Director Lewis BlackAgainstFOR — 7 of 12 T. Rowe Price fundsAgainst—
Almonty Industries Inc.2026-06-09Elect Director Mark TrachukAgainstFOR — 7 of 12 T. Rowe Price fundsAgainst—
Urban Outfitters, Inc.2026-06-03Election of Directors: Amin N. MarediaForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Edward N. AntoianForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 97.6% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Harry S. Cherken, Jr.ForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 98.4% support
Urban Outfitters, Inc.2026-06-03Election of Directors: John C. MullikenForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 97.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Kelly CampbellForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 99.3% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Mary C. EganForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 98.7% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Todd R. MorgenfeldForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 99.1% support
Urban Outfitters, Inc.2026-06-03Election of Directors: Wesley S. McDonaldForAGAINST — 5 of 8 T. Rowe Price fundsForPassed (calculated), 98.3% support
Element Solutions Inc2026-05-04Advisory vote to approve the Company's 2025 executive compensationForAGAINST — 6 of 10 T. Rowe Price fundsForFailed (calculated), 41.4% support
Flagstar Bank, N.A.2026-06-09An advisory vote to approve, on a non-binding basis, compensation of our named executive officers disclosed in the accompanying proxy statement.ForAGAINST — 6 of 10 T. Rowe Price fundsForPassed (calculated), 81.2% support
Interparfums, Inc.2025-09-10To vote for the advisory resolution to approve executive compensation.ForAGAINST — 5 of 8 T. Rowe Price fundsForApproved, 84.3% support
Marqeta, Inc.2026-06-10To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.AgainstFOR — 5 of 8 T. Rowe Price fundsAgainstPassed (calculated), 78.7% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Judson (Jud) LiWithholdFOR — 5 of 8 T. Rowe Price fundsAgainstPassed (calculated), 92.2% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Martha CummingsWithholdFOR — 5 of 8 T. Rowe Price fundsAgainstPassed (calculated), 82.1% support
Marqeta, Inc.2026-06-10To elect the four Class II nominees for director named in the accompanying proxy statement to hold office until the annual meeting of stockholders in 2029 and until their successors have been duly elected and qualified, or until such director's earlier death, resignation, or removal: Najuma AtkinsonWithholdFOR — 5 of 8 T. Rowe Price fundsAgainstPassed (calculated), 87.8% support
Pinnacle Financial Partners, Inc.2025-11-06A proposal to approve and adopt the Agreement and Plan of Merger by and among Pinnacle Financial Partners, Inc. ("Pinnacle"), Synovus Financial Corp. ("Synovus") and Steel Newco Inc. ("Newco"), dated as of July 24, 2025 (as amended from time to time, the "merger agreement"), pursuant to which, on thAgainstFOR — 4 of 6 T. Rowe Price fundsAgainst—
Clean Harbors, Inc.2026-05-20To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: John R. WelchForWITHHOLD — 4 of 6 T. Rowe Price fundsForPassed (calculated), 98.5% support
Clean Harbors, Inc.2026-05-20To elect four (4) Class I members of the Board of Directors of the Company to serve until the 2029 Annual Meeting of Shareholders: Shelley Stewart, Jr.ForWITHHOLD — 4 of 6 T. Rowe Price fundsForPassed (calculated), 99.4% support
Advanced Energy Industries, Inc.2026-05-07Approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan; andForAGAINST — 4 of 6 T. Rowe Price fundsForApproved, 78.4% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Abid RizviForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Alissa AhlmanForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Mary BaglivoForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 97.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Richard ZanninoForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 95.8% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Robert FischForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 97.3% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stanley FleishmanForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 90.7% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Stephen WhiteForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 97.5% support
Ollie's Bargain Outlet Holdings, Inc.2026-06-11Election of Directors of the Board to hold office until the 2027 Annual Stockholders Meeting or until their respective successors have been elected and qualified: Thomas HendricksonForAGAINST — 6 of 11 T. Rowe Price fundsForPassed (calculated), 97.0% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander PlouffeForWITHHOLD — 5 of 9 T. Rowe Price fundsForPassed (calculated), 99.5% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha SankaranForWITHHOLD — 5 of 9 T. Rowe Price fundsForPassed (calculated), 99.7% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIForWITHHOLD — 5 of 9 T. Rowe Price fundsForPassed (calculated), 96.9% support
Miami International Holdings, Inc.2026-06-16The approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 5 of 9 T. Rowe Price fundsForPassed (calculated), 73.9% support
PBF Energy Inc.2026-04-28Election of Directors: Spencer AbrahamForAGAINST — 4 of 7 T. Rowe Price fundsForElected, 89.4% support
Element Solutions Inc2026-05-04Election of Directors: E. Stanley O'NealAgainstFOR — 4 of 7 T. Rowe Price fundsAgainstPassed (calculated), 94.2% support
ESCO Technologies Inc.2026-01-30Election of Directors: Patrick M. DewarForWITHHOLD — 4 of 7 T. Rowe Price fundsForElected, 96.4% support
ESCO Technologies Inc.2026-01-30Election of Directors: Vinod M. KhilnaniForWITHHOLD — 4 of 7 T. Rowe Price fundsForElected, 96.6% support
Flagstar Bank, N.A.2026-06-09Election of Directors: Marshall LuxForAGAINST — 4 of 7 T. Rowe Price fundsForElected, 98.0% support
Ambarella, Inc.2026-06-26Election of Directors: D. Jeffrey RichardsonForWITHHOLD — 4 of 7 T. Rowe Price fundsForElected, 89.0% support
Ambarella, Inc.2026-06-26Election of Directors: Elizabeth M. SchwartingForWITHHOLD — 4 of 7 T. Rowe Price fundsForElected, 80.4% support
Capstone Copper Corp.2026-04-30Amend Incentive Share Option and Bonus Share PlanForAGAINST — 4 of 7 T. Rowe Price fundsFor—
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: Kathryn K. ChouForWITHHOLD — 3 of 5 T. Rowe Price fundsForElected, 71.3% support
IonQ, Inc.2026-06-16To elect two Class II directors to hold office until our 2029 Annual Meeting of Stockholders and until a successor is duly elected and qualified or until earlier resignation or removal: William F. ScannellForWITHHOLD — 3 of 5 T. Rowe Price fundsForElected, 83.0% support
Prosperity Bancshares, Inc.2026-04-21Election of four (4) Class I directors to serve on the Board of Directors of the Company until the Company's 2029 annual meeting of shareholders: Harrison Stafford II (Class I)ForWITHHOLD — 3 of 5 T. Rowe Price fundsForPassed (calculated), 96.3% support
Prosperity Bancshares, Inc.2026-04-21Election of four (4) Class I directors to serve on the Board of Directors of the Company until the Company's 2029 annual meeting of shareholders: Perry Mueller, Jr. (Class I)ForWITHHOLD — 3 of 5 T. Rowe Price fundsForPassed (calculated), 87.8% support
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. LeonardForAGAINST — 3 of 5 T. Rowe Price fundsFor—
Surgery Partners, Inc.2026-06-05Election of Class II Directors: Brent TurnerForWITHHOLD — 3 of 5 T. Rowe Price fundsForElected, 96.9% support

Download all 86 differences (CSV)

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3,9637
Corporate Governance60273
Audit-related5301
Compensation4557
Capital Structure4390
Say-on-Pay3701
Other Social Issues6644
Extraordinary Transactions492
Environment or Climate4747
Other210

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Microsoft CorporationDecember 5, 2025$6M216
Apple Inc.February 24, 2026$5M121
NVIDIA CorporationJune 24, 2026$5M164
Meta Platforms, Inc.May 27, 2026$3M229
Amazon.com, Inc.May 20, 2026$3M174
Broadcom Inc.April 20, 2026$2M100
Visa Inc.January 27, 2026$2M184
JPMorgan Chase & Co.May 19, 2026$1M174

Notable votes against management

MeetingCompanyProposalFundMgmt
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding report on Al data usage oversight. Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
January 27, 2026Visa Inc.Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. Shareholder proposalAgainstFor
January 27, 2026Visa Inc.Shareholder proposal on shareholder right to act by written consent. Shareholder proposalAgainstFor
May 19, 2026JPMorgan Chase & Co.Report on congruence of security, resiliency, and climate initiatives Shareholder proposalAgainstFor

Funds that vote the same way

These funds reported the same votes as T. Rowe Price Moderate Allocation Portfolio in the latest season (or all but a few items), so they share this page:

Search this fund’s votes by company

6,579 ballot items at 556 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, T. Rowe Price Moderate Allocation Portfolio (QAAGRX) voted at 556 shareholder meetings of 530 companies, on 6,579 ballot items in all. Where management made a recommendation, the fund followed it on 96.8% of the items and voted against it 206 times. Its most frequent area of disagreement was corporate governance (73 of its votes against management). It voted FOR 12.0% of the 208 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than T. Rowe Price's funds as a whole (95.9% against 93.7%). It voted differently from most T. Rowe Price funds on 86 items.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of T. Rowe Price’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.